Janku Filip

CIK 00018629301 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001862930

Recent Transactions

25 trades

Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-06-30$13.41/sh+5,407→ 66,019 total
Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2026-06-30−5,407→ 81,093 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-06-30$24.50/sh−5,407→ 60,612 total
Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2026-06-29−6,000→ 60,000 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-06-29$22.95/sh−6,000→ 59,992 total
Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-06-29$7.56/sh+6,000→ 65,992 total
Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-06-24$7.56/sh+30,000→ 89,992 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-06-24$21.42/sh−30,000→ 59,992 total
Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2026-06-24−30,000→ 66,000 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-06-23$20.22/sh−11,845→ 59,992 total
Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2026-06-23−6,000→ 96,000 total
Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-06-23$7.56/sh+6,000→ 71,837 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-02-23$19.50/sh−9,189→ 65,837 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-01-05$15.17/sh−3,155→ 75,026 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2026-01-02+139,000→ 139,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-01-02+31,000→ 78,181 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2025-01-02+36,000→ 45,189 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2025-01-02+161,000→ 161,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2024-09-13+30,000→ 30,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2024-01-02+121,000→ 121,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2023-01-03+135,000→ 135,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2022-12-15+36,000→ 36,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2022-10-31+36,000→ 36,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2022-03-01+86,500→ 86,500 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2021-06-23+387,069→ 387,069 total

Companies

Monte Rosa Therapeutics, Inc.
Chief Medical Officer
$GLUE

Recent Filings

Address

MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900

BOSTON, MA, 02118

View on SEC.gov